Clinical Trials · NCT01940770
Specific Clinical Experience Investigation for Long-term Use of Bydureon.
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- AstraZeneca
- Enrollment
- 1,137
- Start date
- Oct 2013
- Locations
- 47 sites, Japan
- Primary endpoint
- Adverse event incidence